Drug Discovery Informatics Market size is expected to grow at a CAGR of 9.2% during the forecast period and the market size is expected to reach nearly US$ 4.97 Bn. by 2029.To know about the Research Methodology:-Request Free Sample Report The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis. Global Drug Discovery Informatics Market is segmented by function, solution, end user, and geography. Type segment is classified as hardware systems and software solutions. Sequencing and target data analysis segment is spearheading the market. Expansive application of informatics solutions in targeted analysis and a large amount of data generated during the drug discovery process are the factors attributed to the growth of sequencing and target data analysis segment. Solution segment is classified as software and services. Software segment is expected to register the highest growth in the forecast period. Factors like fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions are driving the Software segment growth. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Increasing focus on drug discovery is trending the overall Global Drug Discovery Informatics Market. However, high costs associated with the setup of informatics software will restrain the market growth. APAC is going to emerge as one of the higher growth regions in the forecast period followed by North America and Europe. Availability of many qualified researchers and the low cost of human resources and manufacturing in rising economies like China and India will fuel the Global Drug Discovery Informatics Market in the APAC region.
Drug Discovery Informatics Market, Key Highlights:
• Assessment of market definition along with the identification of key players and analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for Global Drug Discovery Informatics Market during the forecast period • Complete quantitative analysis of the industry from 2018 to 2026 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Drug Discovery Informatics Market analysis and comprehensive segmentation with respect to the function, solution, end user, and geography to assist in strategic business planning • Global Drug Discovery Informatics Market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America, and their key regionsDrug Discovery Informatics Market, Research Methodology:
The research methodology used in Global Drug Discovery Informatics Market report contains various secondary sources including directories such as International Trade Administration (ITA), American Association of Pharmaceutical Scientists (AAPS), NCBI, European Federation of Pharmaceutical Industries and Associations (EFPIA) and Pharmaceutical Research and Manufacturers of America (PhRMA). Bloomberg, Hoovers, and Factiva are some of the sites that are being referred to gain insights about Global Drug Discovery Informatics Market. Experts from top manufacturing companies along with other stakeholders have been considered. This is done to validate and collect critical information for evaluating trends related to this market during the forecast period. Top-down and bottom-up approaches have been used to estimate the global and regional size of Global Drug Discovery Informatics Market. Data triangulation techniques along with other comparative analysis are also used to calculate the exact size of the Global Drug Discovery Informatics Market globally.Drug Discovery Informatics Market, Key Target Audience:
• Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • Research institutes • Biotechnology companies • Pharmaceutical companies • Providers of drug discovery informatics solution • Academic institutes • Contract research organizations (CROs) • Government BodiesDrug Discovery Informatics Market Scope: Inquire before buying
Drug Discovery Informatics Market, By Solution: • Services • Software Drug Discovery Informatics Market, By Function: • Sequencing and Target Data Analysis • Docking • Molecular Modelling • Libraries & Database Preparation • Other Function (Screening and ADMET characterization) Drug Discovery Informatics Market, By End User: • Pharmaceutical and Biopharmaceutical Companies • Contract Research Organizations (CROs) • Other End UsersDrug Discovery Informatics Market, by Region:
• North America • Europe • Asia Pacific • Middle East & Africa • Latin America• Novo Informatics • IO Informatics • Openeye Scientific Software • Collaborative Drug Discovery • GVK Biosciences • Certara • Selvita • Charles River Laboratories • Dassault Systèmes • Schrödinger • Perkinelmer • IBM • Jubilant Life Sciences • Thermo Fisher Scientific • Infosys • Eurofins Scientific • Albany Molecular Research Inc. • Accenture • Cognizant • Insilico Medicine • Boehringer Ingelheim International GmbH Frequently Asked Questions: 1. Which region has the largest share in Global Drug Discovery Informatics Market? Ans: Asia Pacific region holds the highest share in 2021. 2. What is the growth rate of Global Drug Discovery Informatics Market? Ans: The Global Drug Discovery Informatics Market is growing at a CAGR of 9.2% during forecasting period 2022-2029. 3. What is scope of the Global Drug Discovery Informatics market report? Ans: Global Drug Discovery Informatics Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Drug Discovery Informatics market? Ans: The important key players in the Global Drug Discovery Informatics Market are – Novo Informatics, IO Informatics, Openeye Scientific Software, Collaborative Drug Discovery, GVK Biosciences, Certara, Selvita, Charles River Laboratories, Dassault Systèmes, Schrödinger, Perkinelmer, IBM, Jubilant Life Sciences, Thermo Fisher Scientific, Infosys, Eurofins Scientific, Albany Molecular Research Inc., Accenture, Cognizant, Insilico Medicine, and Boehringer Ingelheim International GmbH 5. What is the study period of this market? Ans: The Global Drug Discovery Informatics Market is studied from 2021 to 2029.
Drug Discovery Informatics Market Key Players:
1. EXECUTIVE SUMMARY 2. RESEARCH METHODOLOGY 2.1. Market Definition 2.2. Market Scope 2.3. Data Sources 3. MARKET DYNAMICS 3.1. Market Drivers 3.2. Market Restraints 3.3. Market Opportunities 4. END-USER OVERVIEW 4.1. Value Chain Analysis 4.2. Key Trends 5. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION (2021-2029) 5.1. Introduction 5.2. Services 5.2.1. Services Market Overview 5.2.2. Services Market Size & Forecast 5.3. Software 5.3.1. Software Market Overview 5.3.2. Software Market Size & Forecast 6. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION (2021-2029) 6.1. Introduction 6.2. Sequencing and Target Data Analysis 6.2.1. Sequencing and Target Data Analysis Market Overview 6.2.2. Sequencing and Target Data Analysis Market Size & Forecast 6.3. Docking 6.3.1. Docking Market Overview 6.3.2. Docking Market Size & Forecast 6.4. Molecular Modelling 6.4.1. Molecular Modelling Market Overview 6.4.2. Molecular Modelling Market Size & Forecast 6.5. Libraries & Database Preparation 6.5.1. Libraries & Database Preparation Market Overview 6.5.2. Libraries & Database Preparation Market Size & Forecast 6.6. Other Function (Screening and ADMET characterization) 6.6.1. Other Function (Screening and ADMET characterization)Market Overview 6.6.2. Other Function (Screening and ADMET characterization)Market Size & Forecast 7. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY END USER(2021-2029) 7.1. Introduction 7.2. Pharmaceutical and Biopharmaceutical Companies 7.2.1. Pharmaceutical and Biopharmaceutical Companies Market Overview 7.2.2. Pharmaceutical and Biopharmaceutical Companies Market Size & Forecast 7.3. Contract Research Organizations (CROs) 7.3.1. Contract Research Organizations (CROs) Market Overview 7.3.2. Contract Research Organizations (CROs) Market Size & Forecast 7.4. Other End Users 7.4.1. Other End Users Market Overview 7.4.2. Other End Users Market Size & Forecast 8. GLOBAL DRUG DISCOVERY INFORMATICS MARKET, BY GEOGRAPHY (2021-2029) 8.1. North America Drug Discovery Informatics Market 8.1.1. North America Drug Discovery Informatics Market, By Solution 8.1.2. North America Drug Discovery Informatics Market, By Function 8.1.3. North America Drug Discovery Informatics Market, By End User 8.1.4. North America Drug Discovery Informatics Market, by Region 8.1.4.1. U.S. Drug Discovery Informatics Market 8.1.4.2. Canada Drug Discovery Informatics Market 8.1.4.3. Mexico Drug Discovery Informatics Market 8.2. Europe Global Drug Discovery Informatics Market 8.2.1. Europe Drug Discovery Informatics Market, By Solution 8.2.2. Europe Drug Discovery Informatics Market, By Function 8.2.3. Europe Drug Discovery Informatics Market, By End User 8.2.4. Europe Discovery Informatics Market, by Region 8.2.4.1. France Drug Discovery Informatics Market 8.2.4.2. Germany Drug Discovery Informatics Market 8.2.4.3. U.K. Drug Discovery Informatics Market 8.2.4.4. Italy Drug Discovery Informatics Market 8.2.4.5. Spain Drug Discovery Informatics Market 8.2.4.6. Rest of Europe Drug Discovery Informatics Market 8.3. Asia Pacific Drug Discovery Informatics Market 8.3.1. Asia-Pacific Drug Discovery Informatics Market, By Solution 8.3.2. Asia-Pacific Drug Discovery Informatics Market, By Function 8.3.3. Asia-Pacific Drug Discovery Informatics Market, By End User 8.3.4. Asia-Pacific Drug Discovery Informatics Market, by Region 8.3.4.1. China Global Drug Discovery Informatics Market 8.3.4.2. Japan Drug Discovery Informatics Market 8.3.4.3. India Drug Discovery Informatics Market 8.3.4.4. South Korea Drug Discovery Informatics Market 8.3.4.5. Rest of Asia Pacific Drug Discovery Informatics Market 8.4. Middle East & Africa Drug Discovery Informatics Market 8.4.1. Middle East & Africa Drug Discovery Informatics Market, By Solution 8.4.2. Middle East & Africa Drug Discovery Informatics Market, By Function 8.4.3. Middle East & Africa Drug Discovery Informatics Market, By End User 8.4.4. Middle East & Africa Drug Discovery Informatics Market, by Region 8.4.4.1. South Africa Drug Discovery Informatics Market 8.4.4.2. Rest of Middle East and Africa Global Drug Discovery Informatics Market 8.5. Latin America Drug Discovery Informatics Market 8.5.1. Latin America Drug Discovery Informatics Market, By Solution 8.5.2. Latin America Drug Discovery Informatics Market, By Function 8.5.3. Latin America Drug Discovery Informatics Market, By End User 8.5.4. Latin America Drug Discovery Informatics Market, by Region 8.5.4.1. Brazil Drug Discovery Informatics Market 8.5.4.2. Rest of Latin America Global Drug Discovery Informatics Market 9. MARKET COMPETITION ANALYSIS 9.1 Market Share/Positioning Analysis 9.2 Key Innovators 9.3 Company Profiles 9.3.1 Novo Informatics 9.3.1.1 Overview 9.3.1.2 Products/ End-User 9.3.1.3 Strategy 9.3.1.4 Key Developments 9.3.2 IO Informatics 9.3.2.1 Overview 9.3.2.2 Products/ End-User 9.3.2.3 Strategy 9.3.2.4 Key Developments 9.3.3 Openeye Scientific Software 9.3.3.1 Overview 9.3.3.2 Products/ End-User 9.3.3.3 Strategy 9.3.3.4 Key Developments 9.3.4 Collaborative Drug Discovery 9.3.4.1 Overview 9.3.4.2 Products/ End-User 9.3.4.3 Strategy 9.3.4.4 Key Developments 9.3.5 GVK Biosciences 9.3.5.1 Overview 9.3.5.2 Products/ End-User 9.3.5.3 Strategy 9.3.5.4 Key Developments 9.3.6 Certara 9.3.6.1 Overview 9.3.6.2 Products/ End-User 9.3.6.3 Strategy 9.3.6.4 Key Developments 9.3.7 Selvita 9.3.7.1 Overview 9.3.7.2 Products/ End-User 9.3.7.3 Strategy 9.3.7.4 Key Developments 9.3.8 Charles River Laboratories 9.3.8.1 Overview 9.3.8.2 Products/ End-User 9.3.8.3 Strategy 9.3.8.4 Key Developments 9.3.9 Dassault Systèmes 9.3.9.1 Overview 9.3.9.2 Products/ End-User 9.3.9.3 Strategy 9.3.9.4 Key Developments 9.3.10 Schrödinger 9.3.10.1 Overview 9.3.10.2 Products/ End-User 9.3.10.3 Strategy 9.3.10.4 Key Development 9.3.11 Perkinelmer 9.3.11.1 Overview 9.3.11.2 Products/ End-User 9.3.11.3 Strategy 9.3.11.4 Key Development 9.3.12 IBM 9.3.12.1 Overview 9.3.12.2 Products/ End-User 9.3.12.3 Strategy 9.3.12.4 Key Development 9.3.13 Jubilant Life Sciences 9.3.13.1 Overview 9.3.13.2 Products/ End-User 9.3.13.3 Strategy 9.3.13.4 Key Development 9.3.14 Thermo Fisher Scientific 9.3.14.1 Overview 9.3.14.2 Products/ End-User 9.3.14.3 Strategy 9.3.14.4 Key Development 9.3.15 Infosys 9.3.15.1 Overview 9.3.15.2 Products/ End-User 9.3.15.3 Strategy 9.3.15.4 Key Development 9.3.16 Eurofins Scientific 9.3.16.1 Overview 9.3.16.2 Products/ End-User 9.3.16.3 Strategy 9.3.16.4 Key Development 9.3.17 Albany Molecular Research Inc. 9.3.17.1 Overview 9.3.17.2 Products/ End-User 9.3.17.3 Strategy 9.3.17.4 Key Development 9.3.18 Accenture 9.3.18.1 Overview 9.3.18.2 Products/ End-User 9.3.18.3 Strategy 9.3.18.4 Key Development 9.3.19 Cognizant 9.3.19.1 Overview 9.3.19.2 Products/ End-User 9.3.19.3 Strategy 9.3.19.4 Key Development 9.3.20 Insilico Medicine 9.3.20.1 Overview 9.3.20.2 Products/ End-User 9.3.20.3 Strategy 9.3.20.4 Key Development 9.3.21 Boehringer Ingelheim International GmbH 9.3.21.1 Overview 9.3.21.2 Products/ End-User 9.3.21.3 Strategy 9.3.21.4 Key Development